In ovarian cancer, both KLK5 [38] and KLK7 [39] expression levels were previously reported to be up-regulated in ovarian neoplasms, compared to benign and/or low malignant potential carcinomas, indicating that they may represent diagnostic factors in this tumor entity. This evidence concerns the gene KLK5 and ovarian carcinoma.